• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬血细胞性淋巴组织细胞增生症,是“急性 COVID-19 综合征后”的一种新的死亡原因?一例病例报告。

Hemophagocytic lymphohistiocytosis, a new cause of death during 'post-acute COVID-19 syndrome?' A case report.

作者信息

Naous Elie, Nassani Bertha-Maria, Yaghi Cesar, Nasr Fadi, Medlej Rita

机构信息

Department of Internal Medicine, Endocrinology Division, Hotel Dieu de France Hospital, Beirut, Lebanon.

Saint Joseph University, Beirut, Lebanon.

出版信息

J Hematop. 2021 Apr 20;14(3):229-233. doi: 10.1007/s12308-021-00452-w. eCollection 2021 Sep.

DOI:10.1007/s12308-021-00452-w
PMID:33897909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8057656/
Abstract

'Post-acute coronavirus disease 2019 (COVID-19) syndrome' is a new term that was coined to describe a constellation of persistent symptoms and new complications following recovery from COVID-19 initial illness. Identifying post-COVID-19 complications is crucial for early diagnosis and subsequent initiation of therapies to ensure more favorable outcomes. Severe COVID-19-related hemophagocytic lymphohistiocytosis (HLH) has been previously described during the acute phase of the infection. It is characterized by hyperinflammation, multi-organ involvement, and hemophagocytosis. We report the case of a 69-year-old woman who presented, two weeks after recovery from COVID-19, with hyperosmolar state and high inflammatory markers. Bone marrow aspirate, flow cytometry, extensive viral panel and total body scan were performed. Review of bone marrow aspirate smear showed hemophagocytosis. Flow cytometry, viral panel, and total body scan were normal. The diagnosis of post COVID-19-related HLH was made. Unfortunately, the patient died despite adequate treatment. To our knowledge, this is the first case establishing a high probability of COVID-19-related HLH given its occurrence two weeks following a documented biological and clinical recovery. Awareness and early recognition of HLH features following COVID-19 recovery should prompt timely initiation of therapy.

摘要

“新型冠状病毒肺炎(COVID-19)后综合征”是一个新术语,用于描述COVID-19初发疾病康复后出现的一系列持续症状和新并发症。识别COVID-19后并发症对于早期诊断及随后启动治疗以确保更有利的结果至关重要。此前曾报道过在感染急性期出现的严重COVID-19相关噬血细胞性淋巴组织细胞增生症(HLH)。其特征为炎症反应过度、多器官受累及噬血细胞现象。我们报告了一例69岁女性病例,该患者在COVID-19康复两周后出现高渗状态及高炎症标志物。进行了骨髓穿刺、流式细胞术、广泛病毒检测及全身扫描。骨髓穿刺涂片检查显示有噬血细胞现象。流式细胞术、病毒检测及全身扫描均正常。确诊为COVID-19相关HLH。不幸的是,尽管给予了充分治疗,患者仍死亡。据我们所知,鉴于该病例在有记录的生物学和临床康复两周后发生,这是首例高度疑似COVID-19相关HLH的病例。对COVID-19康复后HLH特征的认识和早期识别应促使及时启动治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/8057656/996b05b6537b/12308_2021_452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/8057656/996b05b6537b/12308_2021_452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb0/8057656/996b05b6537b/12308_2021_452_Fig1_HTML.jpg

相似文献

1
Hemophagocytic lymphohistiocytosis, a new cause of death during 'post-acute COVID-19 syndrome?' A case report.噬血细胞性淋巴组织细胞增生症,是“急性 COVID-19 综合征后”的一种新的死亡原因?一例病例报告。
J Hematop. 2021 Apr 20;14(3):229-233. doi: 10.1007/s12308-021-00452-w. eCollection 2021 Sep.
2
A case of Hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature.由 COVID-19 引起的噬血细胞性淋巴组织细胞增生症病例,并对文献中所有报告的病例进行回顾。
J Infect Dev Ctries. 2021 Nov 30;15(11):1607-1614. doi: 10.3855/jidc.14829.
3
SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.严重急性呼吸综合征冠状病毒 2 感染相关性噬血细胞性淋巴组织细胞增生症。
Am J Clin Pathol. 2020 Sep 8;154(4):466-474. doi: 10.1093/ajcp/aqaa124.
4
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.COVID-19 相关细胞因子风暴综合征与诊断原则:一个古老而崭新的议题。
Emerg Microbes Infect. 2021 Dec;10(1):266-276. doi: 10.1080/22221751.2021.1884503.
5
Probable secondary hemophagocytic lymphohistiocytosis manifesting as central nervous system lesions after COVID-19 vaccination: a case report.新冠病毒疫苗接种后表现为中枢神经系统病变的可能继发性噬血细胞性淋巴组织细胞增生症:一例报告
Front Neurol. 2024 Mar 11;15:1363072. doi: 10.3389/fneur.2024.1363072. eCollection 2024.
6
Secondary Hemophagocytic Lymphohistiocytosis in a Neonate with SARS-CoV-2 Infection.新生儿 SARS-CoV-2 感染相关性噬血细胞性淋巴组织细胞增生症。
Am J Case Rep. 2022 Jan 28;23:e934839. doi: 10.12659/AJCR.934839.
7
Secondary Hemophagocytic Lymphohistiocytosis in a Post-COVID-19 Patient.一名新冠肺炎康复患者出现继发性噬血细胞性淋巴组织细胞增生症
Cureus. 2022 Feb 26;14(2):e22620. doi: 10.7759/cureus.22620. eCollection 2022 Feb.
8
Hemophagocytic Lymphohistiocytosis Secondary to Acute Human Immunodeficiency Virus and COVID-19.继发于急性人类免疫缺陷病毒和新型冠状病毒肺炎的噬血细胞性淋巴组织细胞增生症
J Med Cases. 2024 Sep;15(9):222-226. doi: 10.14740/jmc4226. Epub 2024 Aug 10.
9
Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review.COVID-19 后生存患者经骨髓活检诊断噬血细胞性淋巴组织细胞增生症:病例报告及迷你综述。
J Mol Histol. 2022 Aug;53(4):753-762. doi: 10.1007/s10735-022-10088-4. Epub 2022 Jun 14.
10
Coronavirus Does It Again: Post-COVID-19 Hemophagocytic Lymphohistiocytosis (HLH).冠状病毒再次作祟:新冠后噬血细胞性淋巴组织细胞增生症(HLH)
Cureus. 2023 Feb 21;15(2):e35275. doi: 10.7759/cureus.35275. eCollection 2023 Feb.

引用本文的文献

1
Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism.病例报告:一名患有表型不明显的部分白化病的年轻女性发生迟发性原发性噬血细胞性淋巴组织细胞增生症,最终诊断为2型格里塞利综合征。
Front Immunol. 2025 Aug 7;16:1604460. doi: 10.3389/fimmu.2025.1604460. eCollection 2025.
2
Hemophagocytic Lymphohistiocytosis Secondary to Refractory Acute Myeloid Leukemia Resolved after Second-Line Treatment with Azacitidine plus Venetoclax.难治性急性髓系白血病继发噬血细胞性淋巴组织细胞增生症经阿扎胞苷联合维奈克拉二线治疗后缓解
Mediterr J Hematol Infect Dis. 2024 Jan 1;16(1):e2024011. doi: 10.4084/MJHID.2024.011. eCollection 2024.
3

本文引用的文献

1
Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.COVID-19 相关噬血细胞性淋巴组织细胞增生症:逐步治疗方法的病例报告。
Medicine (Baltimore). 2021 Mar 26;100(12):e25170. doi: 10.1097/MD.0000000000025170.
2
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?新型冠状病毒肺炎与细胞因子风暴综合征:巨噬细胞活化综合征能带来哪些启示?
Transl Res. 2021 Jun;232:1-12. doi: 10.1016/j.trsl.2021.03.002. Epub 2021 Mar 5.
3
Bone Marrow and Peripheral Blood Findings in Patients Infected by SARS-CoV-2.
A review on human reproductive systems encountering with the severe acute respiratory syndrome coronavirus 2 infection.关于人类生殖系统遭遇严重急性呼吸综合征冠状病毒2感染的综述。
Int J Reprod Biomed. 2023 Feb 8;21(1):1-16. doi: 10.18502/ijrm.v21i1.12661. eCollection 2023 Jan.
4
A case of hemophagocytic lymphohistiocytosis in a hemodialysis patient with coronavirus disease 2019.一例 2019 冠状病毒病血液透析患者发生噬血细胞性淋巴组织细胞增生症。
CEN Case Rep. 2023 Nov;12(4):390-396. doi: 10.1007/s13730-023-00776-9. Epub 2023 Mar 3.
5
Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and Fungemia in Post-acute COVID-19 Syndrome: A Clinical Challenge.病例报告:急性 COVID-19 综合征后继发性噬血细胞性淋巴组织细胞增生症(sHLH)和真菌血症:一项临床挑战。
Front Med (Lausanne). 2022 Jun 17;9:835421. doi: 10.3389/fmed.2022.835421. eCollection 2022.
6
Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review.COVID-19 后生存患者经骨髓活检诊断噬血细胞性淋巴组织细胞增生症:病例报告及迷你综述。
J Mol Histol. 2022 Aug;53(4):753-762. doi: 10.1007/s10735-022-10088-4. Epub 2022 Jun 14.
7
Post-acute coronavirus disease 2019 (COVID 19) syndrome: .2019年冠状病毒病(COVID-19)急性后综合征:
Clin Infect Pract. 2022 Jul;15:100144. doi: 10.1016/j.clinpr.2022.100144. Epub 2022 Apr 26.
8
Secondary Hemophagocytic Lymphohistiocytosis in a Post-COVID-19 Patient.一名新冠肺炎康复患者出现继发性噬血细胞性淋巴组织细胞增生症
Cureus. 2022 Feb 26;14(2):e22620. doi: 10.7759/cureus.22620. eCollection 2022 Feb.
9
Secondary Hemophagocytic Lymphohistiocytosis in Post-COVID-19 Patients: A Report of Two Cases.新冠后患者继发性噬血细胞性淋巴组织细胞增生症:两例报告
Cureus. 2021 Aug 20;13(8):e17328. doi: 10.7759/cureus.17328. eCollection 2021 Aug.
10
Haemophagocytic lymphohistiocytosis in an adult with postacute COVID-19 syndrome.成人新冠感染后(postacute COVID-19)综合征相关噬血细胞性淋巴组织细胞增生症。
BMJ Case Rep. 2021 Sep 13;14(9):e245031. doi: 10.1136/bcr-2021-245031.
新型冠状病毒感染者骨髓和外周血的发现。
Am J Clin Pathol. 2021 Apr 26;155(5):627-637. doi: 10.1093/ajcp/aqaa274.
4
Haemophagocytic syndrome and COVID-19.噬血细胞综合征与 COVID-19。
Clin Rheumatol. 2021 Apr;40(4):1233-1244. doi: 10.1007/s10067-020-05569-4. Epub 2021 Jan 3.
5
Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System.在大型多医院系统中,COVID-19 患者初始出院后的再入院和死亡情况。
JAMA. 2021 Jan 19;325(3):304-306. doi: 10.1001/jama.2020.21465.
6
Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia.病例报告:新型冠状病毒肺炎合并噬血细胞性淋巴组织细胞增生症及广泛肺微血管损伤的致命组合。
J Hematop. 2020 Oct 23;14(1):79-83. doi: 10.1007/s12308-020-00423-7. eCollection 2021 Mar.
7
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.托珠单抗治疗新型冠状病毒肺炎患者并发噬血细胞性淋巴组织细胞增生症:一例报告
J Med Case Rep. 2020 Oct 15;14(1):187. doi: 10.1186/s13256-020-02503-9.
8
Hemophagocytic syndrome and COVID-19.噬血细胞综合征与新型冠状病毒肺炎
Respir Med Case Rep. 2020 Jul 10;31:101162. doi: 10.1016/j.rmcr.2020.101162. eCollection 2020.
9
SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.严重急性呼吸综合征冠状病毒 2 感染相关性噬血细胞性淋巴组织细胞增生症。
Am J Clin Pathol. 2020 Sep 8;154(4):466-474. doi: 10.1093/ajcp/aqaa124.
10
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.COVID-19 患者的病理性炎症:单核细胞和巨噬细胞的关键作用。
Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6.